Welcome to our dedicated page for TD SYNNEX CORPORATION SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vendor concentration, acquisition costs, and supply-chain swings make TD SYNNEX’s regulatory disclosures far from light reading. If you have ever opened a 10-K hoping to isolate cloud revenue or searched dozens of Form 4s for executive stock moves, you know the challenge of decoding this solutions aggregator’s complex numbers.
Stock Titan solves that problem. Our AI-powered summaries turn a 250-page TD SYNNEX annual report 10-K simplified into key takeaways, while real-time alerts surface every TD SYNNEX Form 4 insider transactions real-time. Want the next TD SYNNEX quarterly earnings report 10-Q filing? We post it seconds after EDGAR, then highlight inventory days, gross-margin shifts, and regional sales trends. Need a quick view of material developments? The platform tags each TD SYNNEX 8-K material events explained so you see the impact of new vendor agreements instantly. Even the TD SYNNEX proxy statement executive compensation is distilled, outlining option grants and performance metrics in plain English.
Use the page to:
- Track TD SYNNEX insider trading Form 4 transactions alongside AI-flagged buying patterns
- Compare segments through TD SYNNEX earnings report filing analysis
- Get context for capital raises with TD SYNNEX 8-K material events explained
Whether you are understanding TD SYNNEX SEC documents with AI for strategic planning or monitoring a sudden uptick in TD SYNNEX executive stock transactions Form 4, Stock Titan delivers every form—10-K, 10-Q, 8-K, Form 4, S-8, 424B, and more—complete, searchable, and always current. TD SYNNEX SEC filings explained simply means you spend less time scrolling and more time deciding.
Witt Marshall, Chief Financial Officer of TD SYNNEX Corp (SNX) reported paired transactions on 09/17/2025. He exercised an employee stock option to acquire 861 shares at an exercise price of $57.34 and concurrently sold 861 shares at $149.84 per share pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2025. Following these transactions the reporting person is shown as directly owning 50,638 and 49,777 shares on the two reported lines, and holds 7,749 outstanding option shares that vest over time (20% at first anniversary, then 1/60th monthly).
TD SYNNEX Corp. disclosed a compensation arrangement for Mr. Leung effective September 10, 2025. Under the agreement the company will provide salary continuation for 24 months, payment of the fiscal 2025 Management Incentive Plan bonus at the target amount of approximately $348,500, and a $5,000 lump sum. The agreement also provides for the accelerated vesting of outstanding unvested restricted stock, restricted stock unit and stock option awards, prorated to September 1, 2025 assuming performance at target for performance-based RSUs, and an extension of option exercise periods to 12 months following September 1, 2025. The arrangement contains restrictive covenants, including non-competition and non-solicitation provisions. The full agreement is filed as Exhibit 10.1 and is incorporated by reference.
TD SYNNEX (SNX) director Dennis Polk reported insider sales executed for the Polk family trust under a Rule 10b5-1 trading plan. The reporting person, who is a director and identified as a Hyve Solutions executive, sold shares on 09/04/2025 pursuant to the plan adopted October 13, 2024. The Form 4 shows dispositions of 100 shares at an average price near $147.82, 2,600 shares at an average price near $148.45, and 300 shares at an average price near $149.14. The reporting attorney-in-fact signed the form on 09/05/2025. The filing discloses the sales were made by the Polk family trust of which the reporting person is a trustee and offers to provide transaction-level price details on request.
TD SYNNEX (SNX) Form 144 notice reports a proposed sale of 9,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,331,910 and approximately 82,467,079 shares outstanding, indicating the planned sale represents a small fraction of outstanding stock. The filer acquired most shares as RSA and RSU awards in January 2023. The filing also discloses recent sales over the past three months by the named individual and a related family trust under 10b5-1 plans totaling 29,250 shares for gross proceeds reported.
Witt Marshall, Chief Financial Officer of TD SYNNEX Corporation (SNX), reported transactions on 08/18/2025. The filing shows an exercise of 861 employee stock options at an exercise price of $57.34 per share and a contemporaneous sale of 861 common shares at $147.50 per share. After these transactions the reporting person’s direct beneficial ownership is reported as 49,777 shares for common stock and 8,610 shares held from vested options/derivatives. The reporting person adopted a Rule 10b5-1 trading plan on May 12, 2025, and the filing is signed by an attorney-in-fact on 08/19/2025. The option vests 20% after one year and then 1/60th monthly thereafter.
TD SYNNEX director Ann Vezina reported a sale of 812 shares of TD SYNNEX common stock on 08/13/2025 at $150.42 per share, as disclosed on a Form 4. The filing shows 6,079 shares remain beneficially owned directly after the transaction.
The Form 4 lists the transaction code as S (sale) and is signed by an attorney-in-fact.
TD SYNNEX Corporation submitted a Rule 144 notice reporting a proposed sale of 812 common shares through Raymond James & Associates on the NYSE with an aggregate market value of $122,189 and an approximate sale date of 08/13/2025. The filing lists 82,467,079 shares outstanding.
The securities to be sold were acquired as stock grants on 02/28/2022 (364 shares) and 08/31/2022 (448 shares). The form reports no securities sold in the past three months and includes the signer’s representation that they do not know of any material nonpublic information.
TD SYNNEX CFO Witt Marshall reported transactions on 08/11/2025 showing both an acquisition and a sale of 862 common shares. The filing records an acquisition at a per-share price of $57.34 and a contemporaneous sale at $146.39, leaving the reporting person with 49,777 shares beneficially owned after the sale (the filing also shows 50,639 shares following the acquisition prior to the sale). The filing discloses ownership of 9,471 employee stock options following the reported transactions and notes that the sales were made pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2025.
The Form 4 includes an employee stock option entry with a conversion/exercise price of $57.34 for 862 underlying shares and describes the option vesting schedule. The report is signed on behalf of the reporting person by an attorney-in-fact on 08/12/2025.